Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis

Figure 1

TNFα-blocker administration attenuates clinical CIA. Clinical scores in mice with CIA intraperitoneally treated from day 25 after immunization with PBS (control, C-group, closed squares) or TNFα-blocker (2 mg/week, E-group, open circles) once per week for four weeks. Values are the mean ± SD of 20 mice per group. Differences were significant at (asterisks) for E-group versus C-group at indicated time points.